Up until now, scientific literature regarding medicinal cannabis mineral nutrition has been limited. These findings bolster the Australian cannabis industry’s growth by creating intellectual property and enriching the sector’s knowledge.

We extend our heartfelt gratitude to CSIRO for joining Cannatrek on this journey and contributing to the crucial research that benefits patients across Australia.

The Green Triangle is an exhilarating new research and development collaboration that involves medicinal cannabis industry leaders and researchers from Australia, Japan, and Thailand.

In 2023, Green Triangle partners plan to set up an R&D medicinal cannabis farm near the city of Chiang Mai in northern Thailand. At this location, we will develop landrace strains and a breeding program utilizing Cannatrek genetics.

Our objective is to collect agronomic data and bolster the argument for plant-based medicine production and distribution. By establishing and expanding trade and knowledge transfer relationships, we ultimately aim to simplify and secure access to the necessary treatments for patients.

Unlike the common Monstera or Devil’s Ivy, the cannabis plant has only recently gained recognition for its medical benefits. While the positive effects of plant medicine have just entered the mainstream, Cannatrek founder Tommy Huppert has been aware of the value of plant-based therapies for quite some time.

“It’s an ancient medicine that’s making a comeback, offering an alternative to more traditional chemical medicine,” Tommy explained.

In 2017, Cannatrek initiated its first site in Brisbane, Queensland, featuring a dedicated research and development greenhouse facility. The site generates crucial research and medical treatment for over 30,000 patients.

On April 14, Regional Development Minister Mary-Anne Thomas visited the facility to announce a grant from the Victorian Government’s Regional Jobs Fund for Cannatrek.

Established in 2016, the Australian-owned company produces medical cannabis at its Queensland research and development greenhouse facility for over 6,000 patients.

The Greater Shepparton development will be the first production facility located outside of Queensland.

This project will enable Cannatrek to depend on locally produced cannabis from Australia rather than relying on imports.

I often show people the informal business plan we drafted years ago, which is based on the timeless principle of giving back. I frequently say, “That’s our secret ingredient.”

Our approach is straightforward – we are dedicated to carving out a space for patients where access is difficult.

We envisioned the Cannatrek Foundation even before obtaining our licenses. I’m thrilled to announce that we recently applied to incorporate the Cannatrek Foundation, allowing us to do even more.

Our commitment to giving back remains steadfast. Just last week, my CFO informed me that, in the past 12 months, Cannatrek has provided over $1,000,000 in subsidies to disadvantaged individuals, military veterans, first responders, and low-income patients.

While this is remarkable, there’s still more work to be done. In 2023, we’ll continue our efforts to make medicinal cannabis accessible and affordable for those in need.